Redefining prostate cancer risk stratification: a pioneering strategy to estimate outcome based on Ki67 immunoscoringÂngela Albuquerque-Castro, Cármen Jerónimo, João Lobo et al.|Biomarker Research|2024Cited by 5
Correction: Redefining prostate cancer risk stratification: a pioneering strategy to estimate outcome based on Ki67 immunoscoringÂngela Albuquerque-Castro, Cármen Jerónimo, Catarina Macedo‐Silva et al.|Biomarker Research|2024Cited by 1
Decoding MUC1 and AR axis in a radiation-induced neuroendocrine prostate cancer cell-subpopulation unveils novel therapeutic targetsCatarina Macedo‐Silva, Cármen Jerónimo, Ângela Albuquerque-Castro et al.|Cell Death Discovery|2025Cited by 1
P068 Prostate cancer risk: An innovative approach using Ki67 immunoscoring for outcome estimationCármen Jerónimo, Rui Henrique, Isa Carneiro et al.|European Urology Open Science|2024Cited by 0